Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Toripalimab Plus Surgery vs Surgery Alone for Resectable Recurrent Nasopharyngeal Carcinoma

Sun Yat-sen University · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
nasopharyngeal-carcinomasurgery
nasopharyngeal carcinoma, pd-1, surgery, recurrent, salvage surgery, anti-programmed death-1 antibody, disease free survival, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 966851
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.